Synopsis

Source of validity: Scientific
Rating (out of 5): 2

Lactobacillus brevis has been investigated for its potential benefits in oral health, particularly in the context of oral surgery and post-surgical healing. The scientific justification for its use is based on its properties as a probiotic that can modulate the oral microbiome, inhibit pathogenic bacteria, and possibly promote wound healing. Several small clinical studies and in vitro experiments have shown that L. brevis can reduce inflammation markers, decrease the proliferation of periodontopathogens, and enhance mucosal immunity in the oral cavity. Some evidence suggests that probiotics, including L. brevis, may reduce the incidence of postoperative infections, promote tissue repair, and alleviate symptoms such as pain and swelling after oral surgical procedures like tooth extraction or implant placement.

However, the quality of evidence is limited. Most studies are small, with varying probiotic dosages and formulations, and there is a lack of large-scale, randomized controlled trials specifically focused on L. brevis in oral surgery patients. The current scientific consensus is that while promising, the evidence remains preliminary and does not yet support routine use as a standard adjunctive therapy in oral surgery. The safety profile of L. brevis is generally favorable, but further research is necessary to confirm its efficacy, optimal dosage, and mechanisms of action in the context of oral surgical recovery.

More about lactobacillus brevis
More about Oral Surgery

Other ingredients used for Oral Surgery

Other health conditions supported by lactobacillus brevis

Products containing lactobacillus brevis

Douglas Laboratories Multi-Probiotic ® 40 Billion
Douglas Laboratories Multi-Probiotic ® 40 Billion